
Toll‐like receptors (TLRs) are the critical sensors of innate immunity for triggering immune responses against infections. TLRs are well known to be expressed and activated in innate immune cells, such as macrophage and dendritic cells, but studies have found that some TLRs are also functional in epithelial cells. However, the role of an epithelial TLR in prostate cancer remains elusive. This study shows that TLR5, an innate immunity receptor, is a functional TLR in human prostate cancer epithelial cells. TLR5 plays a vital role in prostate cancer development and is a new potential prognosis biomarker. TLR5 may represent a novel immunotherapy target against prostate cancer.
Like
Save
Share